Skip to content
TechVibe

TechVibe

  • Home
  • Web3
  • Technology
  • Health
  • Business
  • Sports
    • Cricket
    • Football
  • Press Release
  • Contact Us
  • Toggle search form

AIS Healthcare and Grifols Partner for Joint Study to Enhance Patient Care through Advanced Infusion Care

Posted on November 30, 2023 By Haley Bennett

Advanced Infusion Care (AIC), a division of AIS Healthcare, has teamed up with Grifols, a leading global provider of plasma-derived and transfusion medicines, to conduct a joint study. The study will research the effects of subcutaneous immunoglobulin (SCIG) products on people living with primary immune deficiencies (PID). A total of 60 patients beginning their SCIG therapy will be observed over a three-month period to assess any differences in patient experience and satisfaction with immunoglobulin treatments.

The study, called the Satisfaction and Outcomes in Primary Immune Deficiency Patients (SOPID) Study, aims to provide valuable information to physicians, pharmacists, and nurses to ensure patients with immunodeficiencies receive the best possible therapy tailored to their medical and lifestyle needs.

According to data from the National Institute of Allergy and Infectious Diseases, over 200 forms of PID affect approximately 500,000 people in the United States. With a low incidence of serious adverse effects, SCIG treatment is considered an effective method to prevent infections for these individuals. It is also easier to administer, does not require vascular access, can be done at home, and helps maintain a steady state of immunoglobulin levels.

Jud Hall, President of AIC, expressed his pride in partnering with Grifols and emphasized the commitment of both organizations to helping patients fight infections, maintain health, and receive high-quality care.

A recent case study in the National Home Infusion Association’s (NHIA) Infusion Journal highlighted AIC’s model for assessing each patient’s unique circumstances to guide decisions for immunoglobulin treatment. This case study underscored the importance of considering patient preference when choosing the optimal IG therapy approach.

PID and chronic variable immunodeficiency (CVID) are rare genetic disorders that impair the immune system, making IG a lifelong therapy to help individuals fight infections and receive care at home. AIC patient preference played a key role in the treatment approach, transitioning from IVIG to SCIG and ultimately back to IVIG for quality-of-life reasons and personal preferences.

The SOPID study aims to build on the work from the NHIA’s case study to improve physician understanding around how different SCIG products can maximize patient quality of life and provide them with more information as they make decisions and plan long-term treatment strategies.

AIC operates a network of 200 nurses in 40 states, providing patient-specific, in-home infusion services including SCIG treatment. The company recently expanded its services and opened a new pharmacy location, further extending its reach, and ensuring access to comprehensive medications and SCIG therapy to patients across the Mid-Atlantic and Northeast regions.

Both AIS Healthcare and Grifols have a history of providing infusion care to people living with immune deficiencies, contributing to the improvement of patients’ health and overall wellbeing. AIC has been offering Grifols infusion therapy Xembify®, a PID treatment, since 2019.

As a full-service care delivery partner, patients receive a high level of care, including 24/7 access to clinical and support staff. AIC holds contracts with multiple immunoglobulin suppliers, ensuring prescribed therapies are always in stock.

Finally, the SOPID study aims to build comprehensive insights that will help all patients living with PID. This contributed article does not necessarily represent the views of TechTimes.

Haley Bennett

I have over 10 years of experience in the cryptocurrency industry and I have been on the list of the top authors on LinkedIn for the past 5 years. I have a wealth of knowledge to share with my readers, and my goal is to help them navigate the ever-changing world of cryptocurrencies.

Health Tags:advanced, ais, care, grifols, healthcares, improve, in, infusion, joins, joint, patient, study, to

Post navigation

Previous Post: Rohit Sharma and Virat Kohli rested for limited-overs matches in South Africa series, Sanju Samson included in ODI squad, India announces T20I, ODI and Test squads
Next Post: India’s September Quarter GDP Growth Surpasses RBI Estimates at 7.6%

Related Posts

Rephrase the title:AI Can Help US in Developing War Plans Says Experts Amidst China-Taiwan Tension Health
Rephrase the title:Research: Blood Test Offers Accurate, Non-Invasive Alzheimer’s Diagnosis Health
New Study Suggests Hydrogen Fuel Can Compete with Diesel and Gasoline Health
Rephrase the title:Dell Introduces New XPS Lineup with AI-Powered Laptops Ahead of CES 2024 Health
Rephrase the title:NASA Hubble Space Telescope Detects Massive Cyclones Raging on a ‘Hot Jupiter’ Health
Major Energy Industry Players Invest Heavily in Sodium Battery Technology, Signaling Potential Shift in Energy Storage and Electric Vehicle Technology Health

Recent Posts

  • Robin Open Social-Fi: Revolutionizes Gaming with Innovative Integration and Global Partnerships
  • $GUMMY Set to Launch New Meta On Staking on Solana
  • BinoStake.io: Transforming Crypto Investments On BNB Chain with Liquid Staking Solutions
  • Mocaverse to Develop Decentralized Social Layer
  • Expansion of Web3 Fueled by Hong Kong’s Financial Secretary

Categories

  • Business
  • Cricket
  • Football
  • Health
  • Press Release
  • Technology
  • Web3

About Us

Welcome to TechVibe9, where the rhythm of technology meets innovation! We are a group of tech enthusiasts on a mission to uncover and showcase the latest in the tech world.

Mail Us : support@techvibe9.com

Latest Post

  • Robin Open Social-Fi: Revolutionizes Gaming with Innovative Integration and Global Partnerships
  • $GUMMY Set to Launch New Meta On Staking on Solana
  • BinoStake.io: Transforming Crypto Investments On BNB Chain with Liquid Staking Solutions

Helpful Links

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions

Copyright © TechVibe9

Powered by PressBook Masonry Dark